Zelihagül Değim

1.2k total citations
34 papers, 962 citations indexed

About

Zelihagül Değim is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Zelihagül Değim has authored 34 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomaterials, 10 papers in Pharmaceutical Science and 8 papers in Molecular Biology. Recurrent topics in Zelihagül Değim's work include Nanoparticle-Based Drug Delivery (7 papers), Advanced Drug Delivery Systems (6 papers) and Advancements in Transdermal Drug Delivery (6 papers). Zelihagül Değim is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Advanced Drug Delivery Systems (6 papers) and Advancements in Transdermal Drug Delivery (6 papers). Zelihagül Değim collaborates with scholars based in Türkiye, Chile and India. Zelihagül Değim's co-authors include Nevin Çelebi, Deniz Erdoğan, Şükran Yılmaz, Serdar Öztürk, Fatih Zor, Dinç Eşsiz, Ahmet Nacar, Levent Altıntaş, İsmail Tuncer Değim and Hale Sayan and has published in prestigious journals such as International Journal of Pharmaceutics, Life Sciences and Journal of Biomedical Materials Research.

In The Last Decade

Zelihagül Değim

33 papers receiving 934 citations

Peers

Zelihagül Değim

BIOMA

REHAB

Praveen Kolimi United States

Yujun Wang China

Kaijun Gou China

Angela Fabiano Italy

Shwe Phyu Hlaing South Korea

Poonam Parashar India

Anu Gopal India

Ioannis D. Karantas Türkiye

İpek Eroğlu Türkiye

Heba A. Abou‐Taleb Egypt

Praveen Kolimi United States

Zelihagül Değim

233 ×0.6

BIOMA

189 ×0.6

REHAB

238 ×0.9

240 ×1.1

140 ×1.5

Citations per year, relative to Zelihagül Değim Zelihagül Değim (= 1×) peers Praveen Kolimi

Countries citing papers authored by Zelihagül Değim

Since Specialization

Citations

This map shows the geographic impact of Zelihagül Değim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelihagül Değim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelihagül Değim more than expected).

Fields of papers citing papers by Zelihagül Değim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelihagül Değim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelihagül Değim. The network helps show where Zelihagül Değim may publish in the future.

Co-authorship network of co-authors of Zelihagül Değim

This figure shows the co-authorship network connecting the top 25 collaborators of Zelihagül Değim. A scholar is included among the top collaborators of Zelihagül Değim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zelihagül Değim. Zelihagül Değim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akkol, Esra Küpeli, et al.. (2021). Can Carbon Quantum Dots (CQDs) or Boron Compounds be an Ultimate Solution for COVID-19 Therapy?. PubMed Central. 4 indexed citations

Değim, Zelihagül, et al.. (2019). Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma. Drug Development Research. 80(5). 556–565. 24 indexed citations

Değim, Zelihagül, et al.. (2018). Development of Nanocochleates Containing Erlotinib HCl and Dexketoprofen trometamol and Evaluation of In vitro Characteristic Properties. Turkish Journal of Pharmaceutical Sciences. 15(1). 16–21. 13 indexed citations

Yücel, Çiğdem, Yeşim Aktaş, Zelihagül Değim, et al.. (2018). Effects of Insulin and Embryonic Stem Cells loaded PLGA Nanoparticles on Pancreatic Beta TC Cells. Acta Poloniae Pharmaceutica - Drug Research. 75(6). 1377–1389. 1 indexed citations

Değim, Zelihagül, et al.. (2015). The Effectiveness of Raloxifene-Loaded Liposomes and Cochleates in Breast Cancer Therapy. AAPS PharmSciTech. 17(4). 968–977. 45 indexed citations

Yücel, Çiğdem, Zelihagül Değim, & Şükran Yılmaz. (2013). Nanoparticle and liposome formulations of doxycycline: Transport properties through Caco-2 cell line and effects on matrix metalloproteinase secretion. Biomedicine & Pharmacotherapy. 67(6). 459–467. 23 indexed citations

Değim, Zelihagül, et al.. (2011). New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations. Drug Development and Industrial Pharmacy. 37(7). 775–789. 63 indexed citations

Değim, Zelihagül, et al.. (2011). Evaluation of chitosan gel containing liposome-loaded epidermal growth factor on burn wound healing. International Wound Journal. 8(4). 343–354. 70 indexed citations

Değim, Zelihagül. (2008). Use of microparticulate systems to accelerate skin wound healing. Journal of drug targeting. 16(6). 437–448. 45 indexed citations

10.

Değim, Zelihagül, et al.. (2007). Investigation of epidermal growth factor containing liposome formulation effects on burn wound healing. Journal of Biomedical Materials Research Part A. 85A(1). 271–283. 53 indexed citations

11.

Değim, İsmail Tuncer, et al.. (2006). Oral Administration of Liposomal Insulin. Journal of Nanoscience and Nanotechnology. 6(9). 2945–2949. 24 indexed citations

12.

Değim, Zelihagül, et al.. (2006). An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor. Burns. 32(3). 319–327. 252 indexed citations

13.

Değim, Zelihagül. (2005). Prediction of Permeability Coefficients of Compounds Through Caco-2 Cell Monolayer Using Artificial Neural Network Analysis. Drug Development and Industrial Pharmacy. 31(9). 935–942. 8 indexed citations

14.

Değim, Zelihagül, et al.. (2004). Caco-2 Cell Culture as a Model for Famotidine Absorption. Drug Delivery. 12(1). 27–33. 7 indexed citations

15.

Değim, Zelihagül, et al.. (2004). The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer. Life Sciences. 75(23). 2819–2827. 56 indexed citations

16.

Değim, Zelihagül, et al.. (2002). Nonisothermal stability tests of famotidine and nizatidine. Il Farmaco. 57(9). 729–735. 7 indexed citations

17.

Değim, Zelihagül, Nevin Çelebi, Hale Sayan, et al.. (2002). An investigation on skin wound healing in mice with a taurine-chitosan gel formulation.. Amino Acids. 22(2). 187–198. 101 indexed citations

18.

Değim, Zelihagül, et al.. (2002). The use of liposomal enrofloxacin for intracellular infections in Kangal dogs and visualization of phagocytosis of liposomes. Journal of Biomedical Materials Research. 61(2). 246–251. 4 indexed citations

19.

Dündaröz, Ruşen, et al.. (2002). EFFECT OF LONG TERM USE OF HAIR DYES ON THE DNA DAMAGE IN HEALTHY FEMALESUBJECTS. DergiPark (Istanbul University). 3(1). 3 indexed citations

20.

Değim, İsmail Tuncer, et al.. (2001). pH-Metric logK calculations of famotidine, naproxen, nizatidine, ranitidine and salicylic acid. Il Farmaco. 56(9). 659–663. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact